Adaptive Research and Western Radiation Oncology (WRO) have partnered to expand access to cancer treatment studies for individuals in the San Francisco Bay Area.
This partnership is set to provide WRO with research administration, including project management, compliance, regulatory and financial administration along with research staffing and technological solutions for recruitment of patients and data management.
Go deeper with GlobalData
The partnership is a strategic move that reflects Adaptive Research’s commitment to democratise trials.
By making community physicians engage in clinical research, the company is addressing a critical need to accelerate the research and development of potentially transformative cancer treatments.
Moreover, it ensures that a wider range of patients can access clinical trials. It also offers support to WRO in overcoming logistical hurdles.
Adaptive Research CEO Deepak Behera said: “We are pleased to welcome Western Radiation Oncology to our network.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData“By bringing clinical trials directly to community practices, we can provide patients with access to emerging therapies while advancing cancer research in real-world settings.”
Adaptive Research facilitates connections between trial sponsors and community physicians across various therapeutic areas through its centralised services.
This approach is designed to make studies more accessible to diverse subjects.
Western Radiation oncology medical director Dr Ankit Agarwal said: “We are enthusiastic about joining forces with Adaptive Research to provide our patients with access to promising, novel cancer treatment options.
“By actively participating in clinical trials, our patients not only have the opportunity to receive innovative investigational therapies but also contribute to the development of life-saving advancements in cancer care.”
In March 2023, Adaptive Research announced a partnership with AHMC Seton Medical Center aimed at expanding clinical trial access in both inpatient and outpatient settings.
